Published in Diabetes Care on February 01, 2005
Standards of medical care in diabetes--2013. Diabetes Care (2013) 24.85
Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28
Standards of medical care in diabetes--2011. Diabetes Care (2011) 21.94
Standards of medical care in diabetes--2012. Diabetes Care (2012) 20.66
Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78
Screening adults for pre-diabetes and diabetes may be cost-saving. Diabetes Care (2010) 1.44
Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2. J Gen Intern Med (2008) 1.28
The clinical use of hemoglobin A1c. J Diabetes Sci Technol (2009) 1.21
Noninvasive optical screening for diabetes. J Diabetes Sci Technol (2009) 1.19
Prevalence of elevated hemoglobin A1c among patients admitted to the hospital without a diagnosis of diabetes. J Clin Endocrinol Metab (2008) 1.16
Blood spot-based measures of glucose homeostasis and diabetes prevalence in a nationally representative population of young US adults. Ann Epidemiol (2014) 0.86
Cost-effectiveness of screening strategies for identifying pediatric diabetes mellitus and dysglycemia. JAMA Pediatr (2013) 0.85
Beta-cell age calculator, a translational yardstick to communicate diabetes risk with patients: tehran lipid and glucose study. ISRN Family Med (2012) 0.77
Diabetes screening intervals based on risk stratification. BMC Endocr Disord (2016) 0.75
Performance of a Random Glucose Case-Finding Strategy to Detect Undiagnosed Diabetes. Am J Prev Med (2017) 0.75
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med (2006) 19.09
Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study. Ann Intern Med (2004) 6.77
A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab (2008) 4.97
Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (2002) 4.34
Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT). Diabetes Care (2008) 3.45
The direct medical cost of type 2 diabetes. Diabetes Care (2003) 3.23
Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care (2010) 3.20
Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study. Diabetes Care (2006) 2.84
Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care (2006) 2.64
Valuing health-related quality of life in diabetes. Diabetes Care (2002) 2.55
Glycated hemoglobin assessment in clinical practice: comparison of the A1cNow point-of-care device with central laboratory testing (GOAL A1C Study). Diabetes Technol Ther (2005) 2.54
Diabetes reporting as a cause of death: results from the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care (2006) 2.36
Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults. Diabetes Care (2007) 2.20
Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care (2008) 2.04
Opportunistic screening for diabetes in routine clinical practice. Diabetes Care (2004) 2.03
Risk factors for mortality among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care (2007) 1.95
A multivariate logistic regression equation to screen for diabetes: development and validation. Diabetes Care (2002) 1.83
Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study. J Diabetes Complications (2008) 1.77
Association between iron deficiency and A1C Levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care (2010) 1.75
Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes (2006) 1.75
Impact of a preconception counseling program for teens with type 1 diabetes (READY-Girls) on patient-provider interaction, resource utilization, and cost. Diabetes Care (2010) 1.66
Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes. Curr Med Res Opin (2006) 1.65
Predictors of mortality over 8 years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD). Diabetes Care (2012) 1.58
Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT. Diabetes (2011) 1.53
An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes. Diabetes Care (2006) 1.51
Improving diabetes processes of care in managed care. Diabetes Care (2003) 1.50
Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus. Am J Public Health (2006) 1.47
The prevalence of the metabolic syndrome among arab americans. Diabetes Care (2004) 1.46
Decrease in urinary incontinence management costs in women enrolled in a clinical trial of weight loss to treat urinary incontinence. Obstet Gynecol (2012) 1.45
Diagnosis of diabetes using hemoglobin A1c: should recommendations in adults be extrapolated to adolescents? J Pediatr (2010) 1.45
Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes. J Clin Endocrinol Metab (2009) 1.41
Identifying risk factors for racial disparities in diabetes outcomes: the translating research into action for diabetes study. Med Care (2009) 1.39
TeleHealth improves diabetes self-management in an underserved community: diabetes TeleCare. Diabetes Care (2010) 1.37
Preventive counseling among women with histories of gestational diabetes mellitus. Diabetes Care (2007) 1.37
Are health-related quality-of-life and self-rated health associated with mortality? Insights from Translating Research Into Action for Diabetes (TRIAD). Prim Care Diabetes (2009) 1.36
Serum 25-hydroxy vitamin d and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans. Diabetes Care (2010) 1.36
Diabetes as a predictor of change in functional status among older Mexican Americans: a population-based cohort study. Diabetes Care (2003) 1.34
Lack of acculturation is a risk factor for diabetes in arab immigrants in the US. Diabetes Care (2003) 1.32
Epidemiology of diabetes among Arab Americans. Diabetes Care (2003) 1.30
Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD). Diabetes Care (2009) 1.26
An epidemiologic profile of children with diabetes in the U.S. Diabetes Care (2006) 1.26
Subclinical neuropathy among Diabetes Control and Complications Trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy? Diabetes Care (2007) 1.25
Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care (2007) 1.25
Medical costs associated with type 2 diabetes complications and comorbidities. Am J Manag Care (2013) 1.24
Changes in health state utilities with changes in body mass in the Diabetes Prevention Program. Obesity (Silver Spring) (2009) 1.24
A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes. Diabetes Care (2002) 1.24
HbA1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction? J Clin Endocrinol Metab (2010) 1.21
Out-of-pocket costs and diabetes preventive services: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care (2003) 1.19
The association between clinical care strategies and the attenuation of racial/ethnic disparities in diabetes care: the Translating Research Into Action for Diabetes (TRIAD) Study. Med Care (2006) 1.18
DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history. Curr Diab Rep (2010) 1.18
Is physician gender associated with the quality of diabetes care? Diabetes Care (2005) 1.18
Self-efficacy, social support, and associations with physical activity and body mass index among women with histories of gestational diabetes mellitus. Diabetes Educ (2008) 1.16
Stratified patient-centered care in type 2 diabetes: a cluster-randomized, controlled clinical trial of effectiveness and cost-effectiveness. Diabetes Care (2013) 1.15
A computer simulation model of diabetes progression, quality of life, and cost. Diabetes Care (2005) 1.15
Hemoglobin A1c: teaching a new dog old tricks. Ann Intern Med (2010) 1.13
Impact of diabetes on cognitive function among older Latinos: a population-based cohort study. J Clin Epidemiol (2003) 1.11
Managed care organization and the quality of diabetes care: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care (2004) 1.08
Feasibility of group lifestyle intervention for diabetes prevention in Arab Americans. Diabetes Res Clin Pract (2010) 1.08
Renal status among patients using metformin in a primary care setting. Diabetes Care (2005) 1.08
Ethnic differences in glycemic markers in patients with type 2 diabetes. Diabetes Care (2013) 1.07
Temporal trends in recording of diabetes on death certificates: results from Translating Research Into Action for Diabetes (TRIAD). Diabetes Care (2011) 1.07
The impact of a managed care obesity intervention on clinical outcomes and costs: a prospective observational study. Obesity (Silver Spring) (2013) 1.06
Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study. Diabetes Care (2010) 1.05
Thiazolidinediones and fractures: evidence from translating research into action for diabetes. J Clin Endocrinol Metab (2010) 1.05
Complications of dysglycemia and medical costs associated with nondiabetic hyperglycemia. Am J Manag Care (2008) 1.05
Community-based screening for diabetes in Michigan. Diabetes Care (2003) 1.04
Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study. Ann Epidemiol (2003) 1.04
Comparison of hemoglobin A1c with fasting plasma glucose and 2-h postchallenge glucose for risk stratification among women with recent gestational diabetes mellitus. Diabetes Care (2011) 1.03
Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. Diabetes Care (2003) 1.01
Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy. Clin J Am Soc Nephrol (2011) 1.01
Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications). J Am Coll Cardiol (2012) 1.00
Diabetes modeling. Diabetes Care (2003) 1.00
Cost-effectiveness of diabetes education. J Am Diet Assoc (2008) 0.99
Does diabetes care compete with the provision of women's preventive care services? Diabetes Care (2005) 0.98
HbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis. Diabetologia (2013) 0.97
The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) trial: comparing the durability of lispro mix 75/25 and glargine. Diabetes Care (2011) 0.96
Predicting development of proliferative diabetic retinopathy. Diabetes Care (2012) 0.95
Lifestyle intervention to prevent diabetes: intensive and cost effective. Curr Opin Lipidol (2006) 0.95
Effect of a managed care disease management program on diabetes care. Am J Manag Care (2009) 0.94
Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT). Diabetes Care (2009) 0.94
Investing time in health: do socioeconomically disadvantaged patients spend more or less extra time on diabetes self-care? Health Econ (2009) 0.94
The influence of maternal weight and glucose tolerance on infant birthweight in Latino mother-infant pairs. Am J Public Health (2006) 0.94
Health utility scores for people with type 2 diabetes in U.S. managed care health plans: results from Translating Research Into Action for Diabetes (TRIAD). Diabetes Care (2012) 0.93
Medical care costs one year after identification of hyperglycemia below the threshold for diabetes. Med Care (2008) 0.92
Educational disparities in rates of smoking among diabetic adults: the translating research into action for diabetes study. Am J Public Health (2007) 0.92
The intensification of drug therapy for diabetes and its complications: evidence from 2 HMOs. Am J Manag Care (2004) 0.92
Long-term effects of the booster-enhanced READY-Girls preconception counseling program on intentions and behaviors for family planning in teens with diabetes. Diabetes Care (2013) 0.92
Predicting risk for diabetes: choosing (or building) the right model. Ann Intern Med (2009) 0.91
The epidemiology of diabetes and its risk factors among Chaldean Americans. Ethn Dis (2006) 0.91
Educational disparities in health behaviors among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study. BMC Public Health (2007) 0.91